Summary.-In a clinical investigation of observed postoperative survival, 563 patients have been registered for primary surgical treatment of colorectal cancer since 1974. The potential prognostic factors examined within the first days of hospitalization for primary resection included age of the patients, operability, location of the tumour, tumour extension and the preoperative serum CEA level. Statistical treatment of the data revealed that each of the clinical parameters except tumour location covers ranges associated with highly significant differences in survival of the patients. The preoperative serum CEA level gave prognostic information in addition to operability or tumour extension. The prognostic significance of the preoperative CEA level was still evident when selected subgroups of patients with distinct resectability and tumour extension were examined. The results indicate that the preoperative serum CEA level is an independent prognostic parameter.
THE ASSAY for serum carcinoembryonic antigen (CEA) performed in intervals of 2-3 months is the most valuable adjunct to clinical examination in postoperative monitoring of patients with resected colorectal cancer. Consecutively rising CEA levels usually predict disease recurrence several months before clinical detection. The rate of rise of the serum CEA level represents a basis for discriminating between localized recurrence and metastatic spread (Staab et al., 1978; Wood et al., 1980; Steele et al., 1980) . However, there are relatively few studies on the prognostic value of preoperative serunm CEA levels. Wanebo et al. (1978) , Evans et al. (1978) and published a statistical treatment of the correlation of preoperative CEA levels and disease recurrence. In these reports positive correlation was highly significant. In another report preoperative plasma CEA levels of 42 patients correlated inversely with survival at a statistically significant level (Kohler et al., 1980) . Our present study, part of a long-term follow-up of patients with colorectal carcinoma started by us in 1974, was set up to characterize prognostic parameters which could be established within a few days, still during hospitalization of patients for primary treatment. The most important question in this investigation was whether a molecular marker (i.e. the serum CEA level) determined shortly before surgical treatment, does represent a gain in prognostic information in addition to the clinical parameters of tumour extension, site of the tumour and resectability. The data obtained from 563 patients were considered sufficient for a preliminary statistical analysis. The statistical treatment of the data was based on the observed survival, and included subgroups of the main t Reprint requests: Friedriclh-Aliescher-Laboratorium dler 7400 (1978) and in colon carcinomas operated before 1978, an institutional TNMclassification. The criteria of this classification were essentially the same as had been described by Holyoke et al. (1975) (Hansen et at., 1971) according to the instructions given by Roche Diagnostics, Basel. Possible variations in the reagents of the commercial CEA-RIA test kit were controlled on the basis of our own internal CEA standards throughout the years. The inter-assay standard deviation for the CEA determination at concentrations of 5-7 ng CEA/ml serum was + 0-72 and at concentrations of 10-5 ng CEA/ml, + 0-83.
Statistical analysis. Survival curves were computed by the life-table method recommended by Peto et al. (1976 Peto et al. ( , 1977 and the American Joint Committee for Cancer Staging (1977) . To determine the statistical significance of differences between the estimated proportions of observed survival in 2 different groups of patients the logrank test (Peto & Peto, 1972) was used. Deaths registered during the first 30 days after surgery were not considered tumour dependent and were excluded from survival curves and significance calculations.
RESULTS
Observed survival after primary surgery of 563 patients with colorectal carcinomas computed for different location of the tumours (viz. rectum (re), sigmoid colon (sc), ascending + transverse + descending colon and caecum (cc) showed no statistically significant differences in our group of patients. The logrank test yielded P=0 15 for cc vs sc, P=0024 for sc vs rc and P = 0 62 for rc vs cc. Age distribution was comparable in all 3 groups. Further computations to characterize the dependence of observed survival on age, operability, tumour extension and preoperative serum CEA levels were therefore performed without analysis according to tumour location.
In a first step, computations of observed survival curves were performed with subgroups of patients based on criteria of a single prognostic variate. In a second step, combinations of 2 prognostic variables and in a third step, combinations of 3 prognostic variables were used.
Prognostic criteria based on single parameters
In the first set of subgroups, the significance of differences in survival curves based on all registered patients (n=563) was examined for various ranges of age, ranges of 0-2 and 2-4 ,ug/l, but significance was obtained between groups with CEA ranges of 2-4 and 4-10 ug/l, as well as between 4-10 and > 10 ,Lg/l (see Table I ). In addition, Fig. lb shows the observed survival of patients with preoperative CEA levels > 100 ,ug/l (n0= 16), who were also included in the group with CEA levels > 10 ,g/l, and exhibited a distinctly higher risk. To test whether the preoperative serum CEA level is a prognostic factor independent of degree of tumour extension, computations of the survival curves were performed for groups ofpatients with different tumour extension according to preoperative serum CEA levels. The survival curves of these subgroups are given in Fig.  2 . The results showed significant differences between patients with CEA ranges of 0-5 ,ug/l and > 5 ,ug/l in the 4 classes of tumour extension, TL-2NoMo, T3NoMo, T4NoMo and T1-4N1-3Mo (Table II) . We also gave the survival curves of patients with preoperative CEA levels > 10 jug/l, to illustrate the higher risk of these patients. In patients with distant metastasis (TI-4No-3MI) survival was not significantly dependent on preoperative CEA ranges between 0-5 and > 5 ,ug/l (P = 0 2; Table II (Table III) based on preoperative CEA ranges of 0-10 and > 10 ,ug/l, 0-5 and >5, or 0-2 and 2-10 and > 10 jug/l. Similarly, significantly different survival curves were found in subgroups of patients with radical or palliative resection when different stages of tumour extension were considered (Table III) . Not listed in the table is a single patient with distant metastasis (MI) who had undergone radical resection. These data indicate that all three parameters, resectability, tumour extension and preoperative serum CEA levels, are of prognostic value for patients, whether with radically or palliatively resected colorectal cancer. Survival of patients with nonresectable tumours revealed no dependence on preoperative serum CEA levels.
Prognostic value of combinations of three parameters
Final confirmation that the preoperative serum CEA level can be used as independent prognostic parameter was obtained from computations of survival of subgroups of patients with distinct resectability and distinct tumour extension. Patients who had undergone radical resection were subdivided into subgroups with the following tumour extensions: T1-3NoMo, T4NoMo and any tumours with lymph-node metastasis (TI-4Nl-3Mo). T1-2NoMo and T3NoMo tumour stages were combined, since patients with these stages showed no significantly different survival (see Table III ). A single patient with distant metastasis (MI) but radical resection was excluded. Patients who had undergone palliative surgery were represented by only one subgroup (TI-4No-3Mo) since survival of patients with distant metastasis (MI) was not significantly dependent on preoperative CEA levels (see Table II ). The survival curves are shown in Fig. 4 . The differences between survival curves based on preoperative CEA ranges of 0-5 and >5 ,ug/l were significant for patients with radical resection and Tl-3NoMo tumours (Table  IV) 0 1) possibly due to the few patients in the subgroups with the CEA range >5 jug/l. Survival curves of patients who underwent only palliative resection of tumours with or without lymph-node metastasis (TI-4No-3Mo) revealed significant differences between preoperative CEA ranges of 0-10 and > 10 ,g/l (Table  IV) but not between 0-5 and >5 kg/l (P= 0-15).
DISCUSSION
The generally accepted prognostic criteria for tumour surgery are resectability, site of the tumour, tumour extension, age and general condition of the patient. A preliminary statistical analysis to examine the validity of these prognostic parameters, including the preoperative serum CEA level as a molecular marker, was performed with data collected during a long-term post-operative follow-up of 563 patients with colorectal cancer since 1974. All these potentially prognostic criteria were available within a short period of hospitalization for surgery.
The survival curves for various subgroups of patients opened up the possibility of comparing different prognostic parameters, and improving the prognostic information by combinations of 2 or more parameters. Resectability (using the criteria "radical resection", "palliative resection" and "nonresectable") was confirmed as a highly significant prognostic parameter. Considering the site of the tumours in colorectal cancer, it is generally assumed that prognosis improves with the site of the tumour, in the order rectum < sigmoid colon < ascending, transverse, descending colon and caecum. In our 563 patients the tumour sites did not represent a significant prognostic parameter. However, tumour extension had reliable prognostic value. Though the stages of localized tumour extension (Tl-3NoMo) had little prognostic value when compared with each other, they showed a significantly improved survival over T4NoMo tumours. Prognosis became significantly worse when patients had already developed lymphnode metastasis or even distant metastasis. The age of patients at surgery implied prognostic significance for patients <70 and > 70 years. This finding has to take into account that prognostic criteria, such as nonresectability and distant metastasis as well as a generally poorer physical condition, are associated with age over 70 (see Table I ) and could be responsible for the poorer prognosis.
The more important question to be answered in this report was whether a molecular marker (i.e. the preoperative serum CEA level) has prognostic value as a single parameter or in combination with other prognostic parameters. Differences in preoperative CEA ranges between 0-2 and 2-4 jug/l had no prognostic significance. However, differences between survival curves were significant for patients with CEA ranges of 2-4, 4-10 and > 10 ,tg/l independent of other prognostic parameters such as resectability and tumour extension. Survival curves of subgroups of patients based on combinations of the preoperative CEA levels with a second and third prognostic parameter confirmed that distinct preoperative CEA levels can be independent prognostic markers. Exceptions were patients with very poor prognosis, mostly due to far-advanced tumour progression, i.e. patients with distant metastasis or nonresectable tumours, who had a very short survival time. In this group of patients the biological situation might be predominantly influenced by additional physiological disorders such as cachexia, which apparently do not affect the production and secretion of CEA by tumour cells.
Why the level of CEA secretion into the serum by tumour cells before surgery reflects the further development of the malignant disease, even after radical resection of the tumour, is little understood. A possible explanation might be the influence of circulating tumour antigens on immune surveillance as -potential inducers of suppressor cells. Suppressor T cells responsive to tumour antigens prevent both the generation (Greene et al., 1977a, b) and expression (Asherson & Zembala, 1976) of T effector cells. These suppressor T cells persist after surgical removal of the tumour (Fujimoto et al., 1976) whereas the direct blocking effect of tumour antigens and its irnmune complexes against T effector cells observed with tumour-bearer sera disappears within a few days after tumour removal (Hellstr6m et al., 1970) . A second explanation may be a direct correlation of the preoperative serum CEA level with clinically undetectable micrometastasis responsible for the further development of the malignant disease.
The gain in prognostic information represented by distinct ranges of the preoperative serum CEA should facilitate the management of patients for adjuvant postoperative treatment such as chemotherapy or immunotherapy.
It can be expected that early adoption of postoperative treatment might improve the prognosis of patients. A generalization from our results has to be based on our methods. If other CEA test svstems were used, different critical ranges of the preoperative CEA levels would be expected.
